spacer
home > epc > spring 2009 > regulatory risk
PUBLICATIONS
European Pharmaceutical Contractor

Regulatory Risk

As big pharma continually struggles to identify the right strategy in order to satisfy the marketplace demands and deliver expected financial returns, one area that will always remain a priority is the business obligation to patient safety. Managing the regulatory requirement for any pharmaceutical business is a costly process, but one that cannot easily be ignored. As companies continually strive to cut costs, mostly in the form of employee cutbacks, they have to remain totally committed to satisfying the various regulatory authorities’ compliance requirements and, as this can be a resource-hungry exercise, having fewer employees can introduce some risk into their business. Managing this risk is also the key to controlling cost, and companies should have annual key strategic objectives based around how they will successfully control and improve their compliance performance, as the ever changing demands create new and often more difficult challenges.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Brian Szukala is Managing Director of SeerPharma (UK) Ltd, a global training auditing and consultancy business. Brian was previously Head of Training at Pfizer and Abbott Laboratories in the UK, and has been actively involved in developing competence and competency frameworks incorporated into performance management systems. He has worked with various government bodies to advise on UK skills issues within the industry and is currently on the strategic board of SEMTA (Sector Skills Council representing pharmaceuticals) advising on skills and UK competitiveness. He has a wealth of experience in the field of compliance and has presented at numerous seminars, both in the UK and abroad on various compliance, behavioural and productivity improvement topics.

spacer
Brian Szukala
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Paris, 03 December 2019: Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapackeu), which opens in February 2020. The event is the leading exhibition dedicated to pharmaceutical packaging and drug delivery devices, with major industry players set to come together to discuss vital best practices, insights and strategies.
More info >>

White Papers

ConsulTech GmbH

ConsulTech GmbH

ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
More info >>

 
Industry Events

Clinical Trial Supply Europe

11-12 March 2020, Madrid, Spain

The 21st annual edition promises to grow on the success of 2019’s excellent conference which saw delegates from Europe’s largest pharmaceutical companies and biotech innovators come together to discuss, debate and unpack the latest trends in clinical supply chain innovation. 2020 will offer delegates the opportunity to address the growing need for agility within the supply chain in response to increasingly complex trial demands. With a stream dedicated to supply operations and another to innovative uses of technology in the supply chain, delegates will get the chance to gain practical take-aways that they can apply to their own studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement